Pharmaceutical

United Therapeutics gets grant for treatment of pulmonary hypertension using prostacyclin-treated stem cells

Discover a groundbreaking method for treating pulmonary hypertension with stem cells and prostacyclin. Learn more about this innovative patent from United Therapeutics Corp.

Apr 5, 2024 - 00:00
Discover a groundbreaking method for treating pulmonary hypertension with stem cells and prostacyclin. Learn more about this innovative patent from United Therapeutics Corp.
Read the original article

Tags:

Previous Article

Lipocine gets grant for pharmaceutical composition for treating testosterone def...

Next Article

Xencor gets grant for bispecific antibody for treating GPC3-associated cancers

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: Judge blocks required ACA coverage for preventive care; Supreme Court urged to review skinny label case

STAT+: Pharmalittle: Judge blocks required ACA coverage...

Apr 1, 2023

STAT+: A Harvard course seeks to put food on the table in medical education

STAT+: A Harvard course seeks to put food on the table ...

Jan 22, 2024

CDC advisory panel backs changes to Covid vaccination policy

CDC advisory panel backs changes to Covid vaccination p...

Apr 19, 2023